JI

Jean-Louis Imbach

CN CNRS: 22 patents #12 of 11,908Top 1%
EU Emory University: 8 patents #51 of 1,217Top 5%
IP Idenix Pharmaceuticals: 8 patents #16 of 67Top 25%
LI L'Universite Montpellier Ii: 6 patents #3 of 12Top 25%
TF The Uab Research Foundation: 4 patents #95 of 813Top 15%
IP Isis Pharmaceuticals: 4 patents #112 of 400Top 30%
CEA: 2 patents #2,014 of 7,956Top 30%
C. C.N.R.S.: 2 patents #17 of 220Top 8%
TF The University Of Alabama Research Foundation: 2 patents #4 of 32Top 15%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
SY Synthelabo: 1 patents #111 of 219Top 55%
UM Universite De Montpellier: 1 patents #213 of 699Top 35%
AR Agence Nationale De Valorisation De La Recherche: 1 patents #87 of 368Top 25%
📍 Montpellier, FR: #7 of 932 inventorsTop 1%
Overall (All Time): #79,878 of 4,157,543Top 2%
40
Patents All Time

Issued Patents All Time

Showing 1–25 of 40 patents

Patent #TitleCo-InventorsDate
9290533 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2016-03-22
8304532 Method for preparing oligonucleotides Ilaria Adamo, Cecile Dueymes, Andreas Schönberger, Albert Meyer, François Morvan +4 more 2012-11-06
7795238 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2010-09-14
7585851 3′-prodrugs of 2′-deoxy-β-L-nucleosides Martin Bryant, Gilles Gosselin 2009-09-08
7468357 Nucleosides with anti-hepatitis B virus activity Raymond F. Schinazi, Jean-Pierre Sommadossi, Gilles Gosselin 2008-12-23
7439351 2′ or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents Gilles Gosselin, Anne-Marie Aubertin, Jean-Pierre Sommmadossi, Raymond F. Schinazi 2008-10-21
7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2007-12-04
7138376 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Gilles Gosselin, Jean-Pierre Sommadossi 2006-11-21
6989372 Antioxidants, preparation methods and uses Joel Oiry, Jean-Yves Puy, Pascal Clayette, Philippe Fretier 2006-01-24
6979747 Antioxidants, preparation processes and their uses Joel Oiry, Jean-Yves Puy, Pascal Clayette, Philippe Fretier 2005-12-27
6946450 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2005-09-20
6896900 β-L-2'-deoxy-nucleosides for the treatment of HIV infection Gilles Gosselin, Jean-Pierre Sommadossi, Raymond F. Schinazi 2005-05-24
6875751 3′-prodrugs of 2′-deoxy-β-L-nucleosides Martin Bryant, Gilles Gosselin 2005-04-05
6569837 &bgr;-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2003-05-27
6566344 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2003-05-20
6555676 Biologically active phosphotriester-type compounds Gilles Gosselin, Christian Perigaud 2003-04-29
6525033 Nucleosides with anti-hepatitis B virus activity Raymond F. Schinazi, Jean-Pierre Sommadossi, Gilles Gosselin 2003-02-25
6458773 Nucleoside with anti-hepatitis B virus activity Gilles Gosselin, Jean-Pierre Sommadossi, Raymond F. Schinazi 2002-10-01
6444652 &bgr;-L-2'-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2002-09-03
6407077 &bgr;-L nucleosides for the treatment of HIV infection Gilles Gosselin, Jean-Pierre Sommadossi, Raymond F. Schinazi 2002-06-18
6399589 Biologically active phosphotriester-type compounds Gilles Gosselin, Christian Perigaud 2002-06-04
6395716 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Martin Bryant 2002-05-28
6245749 Nucleosides with anti-hepatitis B virus activity Raymond F. Schinazi, Jean-Pierre Sommadossi, Gilles Gosselin 2001-06-12
6124445 Phosphotriester oligonucleotides, amidities and method of preparation Gilles Gosselin, Bernard Rayner, Muthiah Manoharan 2000-09-26
6020482 Phosphotriester type biologically active compounds Gilles Gosselin 2000-02-01